EDG-6289

N/A

Report date: 2025/01/26 18:59:57
NME

Base Information

Drug NameEDG-6289
Drug Alias NameMyosin inhibitor (Edgewise Therapeutics)EDG-6289
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCardiac myosin inhibitors
TargetsCardiac myosin
Therapy Area/IndicationsNeuromuscular DiseasesMuscle HypertoniaDyskinesias +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEdgewise Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEdgewise Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeuromuscular DiseasesMuscle HypertoniaDyskinesias +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A